Novo Nordisk Reports New Head-To-Head Pharmacokinetic Study Adults With Hemophilia B Who Received Single Dose Of Rebinyn Achieved High Factor IX Activity For Longer Than Those Treated With rFIXFc
Benzinga Newsdesk